Pfizer, Inc. (PFE) Tops Q3 EPS by 7c; Raises Buyback Target to $7-$9B; Reaffirms Outlook
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $27.80 -1.14%
EPS Growth %: -12.6%
Financial Fact:
Net income attributable to Pfizer Inc.: 1.32B
Today's EPS Names:
TAYD, PKE, More
EPS Growth %: -12.6%
Financial Fact:
Net income attributable to Pfizer Inc.: 1.32B
Today's EPS Names:
TAYD, PKE, More
Join SI Premium – FREE
Pfizer, Inc. (NYSE: PFE) reported Q3 EPS of $0.62, $0.07 better than the analyst estimate of $0.55. Revenue for the quarter came in at $17.2 billion versus the consensus estimate of $16.43 billion.
Raises its buyback target to $7-$9 billion.
Reaffirms FY11 guidance.
Raises its buyback target to $7-$9 billion.
Reaffirms FY11 guidance.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron Technology (MU) Tops Q4 EPS by $2.26, Offers Guidance
- Florida attorney general sues Pfizer over COVID-19 vaccine marketing claims
- Integra LifeSciences cuts 2026 outlook after Cincinnati flood
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Stock BuybacksSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
